Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Receivables - Net (2019 - 2025)

Historic Receivables - Net for Bicycle Therapeutics (BCYC) over the last 7 years, with Q1 2025 value amounting to $136000.0.

  • Bicycle Therapeutics' Receivables - Net changed N/A to $136000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $136000.0, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2022, which is 10450.0% up from last year.
  • Latest data reveals that Bicycle Therapeutics reported Receivables - Net of $136000.0 as of Q1 2025.
  • In the past 5 years, Bicycle Therapeutics' Receivables - Net ranged from a high of $50.0 million in Q1 2023 and a low of $136000.0 during Q1 2025
  • For the 5-year period, Bicycle Therapeutics' Receivables - Net averaged around $12.5 million, with its median value being $2.0 million (2022).
  • Per our database at Business Quant, Bicycle Therapeutics' Receivables - Net skyrocketed by 207391.3% in 2023 and then tumbled by 9948.33% in 2024.
  • Bicycle Therapeutics' Receivables - Net (Quarter) stood at $1.0 million in 2021, then surged by 104.5% to $2.0 million in 2022, then soared by 2104.89% to $45.1 million in 2023, then crashed by 99.48% to $233000.0 in 2024, then plummeted by 41.63% to $136000.0 in 2025.
  • Its last three reported values are $136000.0 in Q1 2025, $233000.0 for Q2 2024, and $45.1 million during Q2 2023.